TRO19622
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for TRO19622, covering 2016-11-22 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]